| Isolation and characterization of tumor cells from the ascites of ovarian cancer patients: molecular phenotype of chemoresistant ovarian tumors A Latifi, RB Luwor, M Bilandzic, S Nazaretian, K Stenvers, J Pyman, H Zhu, ... Public Library of Science 7 (10), e46858, 2012 | 264 | 2012 |
| Betaglycan: a multifunctional accessory M Bilandzic, KL Stenvers Molecular and cellular endocrinology 339 (1-2), 180-189, 2011 | 159 | 2011 |
| Increasing intracellular bioavailable copper selectively targets prostate cancer cells MA Cater, HB Pearson, K Wolyniec, P Klaver, M Bilandzic, BM Paterson, ... ACS chemical biology 8 (7), 1621-1631, 2013 | 139 | 2013 |
| Loss of betaglycan contributes to the malignant properties of human granulosa tumor cells M Bilandzic, S Chu, PG Farnworth, C Harrison, P Nicholls, Y Wang, ... Molecular endocrinology 23 (4), 539-548, 2009 | 70 | 2009 |
| Therapeutic targeting of collective invasion in ovarian cancer L Moffitt, N Karimnia, A Stephens, M Bilandzic International journal of molecular sciences 20 (6), 1466, 2019 | 59 | 2019 |
| Preimplantation human blastocysts release factors that differentially alter human endometrial epithelial cell adhesion and gene expression relative to IVF success TOED C. Cuman, E.M. Menkhorst, L.J. Rombauts, S. Holden, D. Webster, M ... Human Reproduction, 2013 | 56 | 2013 |
| Keratin-14 (KRT14) positive leader cells mediate mesothelial clearance and invasion by ovarian cancer cells M Bilandzic, A Rainczuk, E Green, N Fairweather, TW Jobling, ... Cancers 11 (9), 1228, 2019 | 52 | 2019 |
| Discovery and validation of novel protein biomarkers in ovarian cancer patient urine JJ Sandow, A Rainczuk, G Infusini, M Makanji, M Bilandzic, AL Wilson, ... PROTEOMICS–Clinical Applications 12 (3), 1700135, 2018 | 45 | 2018 |
| Betaglycan alters NFκB-TGFβ2 cross talk to reduce survival of human granulosa tumor cells M Bilandzic, S Chu, Y Wang, HL Tan, PJ Fuller, JK Findlay, KL Stenvers Molecular Endocrinology 27 (3), 466-479, 2013 | 30 | 2013 |
| A novel “embryo-endometrial” adhesion model can potentially predict “receptive” or “non-receptive” endometrium J Evans, KJ Walker, M Bilandzic, S Kinnear, LA Salamonsen Journal of Assisted Reproduction and Genetics 37, 5-16, 2020 | 27 | 2020 |
| TIMP-2 regulates proliferation, invasion and STAT3-mediated cancer stem cell-dependent chemoresistance in ovarian cancer cells RM Escalona, M Bilandzic, P Western, E Kadife, G Kannourakis, ... BMC cancer 20, 1-24, 2020 | 26 | 2020 |
| Betaglycan blocks metastatic behaviors in human granulosa cell tumors by suppressing NFκB-mediated induction of MMP2 M Bilandzic, Y Wang, N Ahmed, RB Luwor, HJ Zhu, JK Findlay, ... Cancer letters 354 (1), 107-114, 2014 | 26 | 2014 |
| Assessment of ovarian cancer spheroid attachment and invasion of mesothelial cells in real time M Bilandzic, KL Stenvers JoVE (Journal of Visualized Experiments), e51655, 2014 | 26 | 2014 |
| DPP4 inhibitor sitagliptin enhances lymphocyte recruitment and prolongs survival in a syngeneic ovarian cancer mouse model AL Wilson, LR Moffitt, KL Wilson, M Bilandzic, MD Wright, MD Gorrell, ... Cancers 13 (3), 487, 2021 | 19 | 2021 |
| Knockdown of stem cell regulator Oct4A in ovarian cancer reveals cellular reprogramming associated with key regulators of cytoskeleton-extracellular matrix remodelling C Samardzija, DW Greening, R Escalona, M Chen, M Bilandzic, R Luwor, ... Scientific Reports 7 (1), 46312, 2017 | 17 | 2017 |
| Hypoxia regulates DPP4 expression, proteolytic inactivation, and shedding from ovarian cancer cells LR Moffitt, M Bilandzic, AL Wilson, Y Chen, MD Gorrell, MK Oehler, ... International Journal of Molecular Sciences 21 (21), 8110, 2020 | 16 | 2020 |
| Interferon-ε is a tumour suppressor and restricts ovarian cancer ZRC Marks, NK Campbell, NE Mangan, CJ Vandenberg, LJ Gearing, ... Nature 620 (7976), 1063-1070, 2023 | 15 | 2023 |
| Non-invasive fluorescent monitoring of ovarian cancer in an immunocompetent mouse model AL Wilson, KL Wilson, M Bilandzic, LR Moffitt, M Makanji, MD Gorrell, ... Cancers 11 (1), 32, 2018 | 15 | 2018 |
| Endogenous inhibins regulate steroidogenesis in mouse TM3 Leydig cells by altering SMAD2 signalling Y Wang, M Bilandzic, GT Ooi, JK Findlay, KL Stenvers Molecular and Cellular Endocrinology 436, 68-77, 2016 | 9 | 2016 |
| Chemoresistance is mediated by ovarian cancer leader cells in vitro N Karimnia, AL Wilson, E Green, A Matthews, TW Jobling, M Plebanski, ... Journal of Experimental & Clinical Cancer Research 40, 1-13, 2021 | 7 | 2021 |
